Effects of caffeic acid phenethyl ester against doxorubicin-induced neuronal oxidant injury
✍ Scribed by Ersin Fadillioglu; Hasan Erdogan; Mustafa Iraz; Murat Yagmurca
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 909 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0893-6609
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Oxygen‐derived free radicals have been implicated in the pathogenesis of doxorubicin‐induced toxicities. The aim of this study was to investigate the effects of caffeic acid phenethyl ester (CAPE), an antioxidant agent, on doxorubicin‐induced neuronal oxidative injury in rats. The rats were treated with CAPE (10μmol/kg/day i.p.) or saline starting 2 days before a single dose of doxorubicin (20 mg/kg i.p.) or saline. Ten days after the first experiments, the brain was excised to analyze the activities of antioxidant enzymes and levels of malondialdehyde (MDA) and nitric oxide (NO). Doxorubicin alone resulted in higher MDA level in brain tissue than the other groups. The activity of catalase was higher in doxorubicin plus CAPE group than doxorubicin group. There were no significant differences in NO level, glutathione peroxidase (GSH‐Px) and superoxide dismutase activities between the groups. There were negative correlations between GSG‐Px activity and MDA level in both doxorubicin and doxorubicin plus CAPE groups. It can be concluded that doxorubicin induced oxidant injury can be prevented by CAPE treatment through its antioxidant properties in rat brain.
📜 SIMILAR VOLUMES
## Abstract The prevention of doxorubicin (DXR)‐induced cardiotoxicity may be helpful to improve future DXR therapy. The aim of this study was to investigate the cardio‐protective effects of caffeic acid phenethyl ester (CAPE), an antioxidant agent, on DXR‐induced cardiotoxicity. Rats were divided